growth underpin continu success
updat forecast estim
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim
price data
rate updat
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
stori one constant chang firm
found manufactur compon wwii aircraft
final divest industri busi full
transit medic devic thereaft leadership
ceo benson smith compani complet transit
industri conglomer pure-play medic devic manufactur
core busi focus vascular surgeri
firm strategi effect carv nich market
compet thu far remain rel insul
intens competit largest player med-tech
manag target market opportun
compani suppli dispos product
mandatori
procedur creat rel stabl demand associ
cash flow addit product portfolio primarili contain
low dollar valu item along increment innov
allow compani improv margin profil modest
price inflat time combin like-for-lik price
power smith character direct market access core
tenant compani strategi led slowli
acquir foreign distribut partner provid better line
sight end market allow firm captur otherwis
lost distributor margin lead sustain predict gross
smith retir end anticip strategi
like remain unchang new ceo former liam
kelli recent acquisit vascular solut neotract
help improv firm margin profil believ high
price paid limit contribut near term
addit grow goodwil compon firm invest
capit base held histor return wacc wed
like see evid compani trend toward
sustain econom profit gener award moat
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
inc wayn pennsylvania base manufactur hospit
suppli medic devic primarili within vascular access
surgic area firm report eight primari segment vascular north
america sale intervent north america
asia oem geograph exposur
busi primarili account revenu
intern market make remaind
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
slightli rais fair valu estim
firm per share account cash
flow receiv sinc last updat valuat impli
roughli time time estim
adjust earn ebitda respect market-impli
valuat moder larg degre
market price stock near time time time
estim adjust earn ebitda sale
respect appear us market particip
explicitli price sizabl takeout premium share
longer although prefer larger margin safeti
consid share addit discount cash
flow methodolog incorpor cash outflow
announc -- someth believ rel multipl
updat outlook project busi continu
solid perform anticip firm grow
revenu near compound-annual-growth-rate forecast period
meaning ahead prior three-year compound-annual-growth-rate
near outlook newli acquir vascular
solut neotract busi drive expect
acceler growth addit add nearli
respect growth core revenu
addit improv gross margin mix
addit busi inform expect
nearli basi point gross margin gain
baselin one-for-on drop oper
profit forecast consist manag
aspir goal oper margin eclips
come year
expect margin expans come follow
area addit gross margin vascular solut
account basi point forecast acquisit
estim gross margin neotract add
approxim basi point given outsiz growth
profil core margin improv make
remain basi point expect core
improv come cost reduct attribut
alreadi announc restructur initi expect
complet addit upsid stem
continu progress distributor-to-direct convers
given uncertainti creat integr sizabl
acquisit complet cours
increas risk associ arguabl stretch
balanc sheet rate uncertainti high
bull case incorpor busi fundament valuat
believ would like associ
acceler period enhanc growth
profil vascular solut neotract result
compound-annual-growth-rate forecast period addit
assum manag oper margin target
realiz two year sooner base case estim
result valu per share approxim
time time time bull-cas forecast
adjust earn ebitda sale respect
bear-cas forecast contempl scenario
sizabl impair goodwil would like occur
case forecast slow core revenu growth less
stellar contribut recent acquisit
result revenu compound-annual-growth-rate line busi
done last three year near addit
estim restructur effort fail meaning
expand core gross margin oper expens
level fail meet exist synergi target
still expect oper margin expand case
forecast fall well short manag target
result valuat per share nearer time
time time lower estim
adjust earn ebitda sale
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
believ help insul busi
industrywid price pressur thu far actual
allow compani rais price modestli time
howev believ manag act
price opportun avail compani assum
price benefit go forward mix relat rather
like-for-lik price power view firm vascular
surgic anesthesia franchis area like
develop futur moat firm respiratori
oem busi rather commodit
overal focus acquir product
top three four competitor make gener
two third total market vascular access
cathet laryng mask laparoscop surgeri
gener compet hand firm
mani case lead product arrow
line central cathet lma laryng mask portfolio
competit posit current favor
clear firm develop sourc
advantag give us confid abil defend
better capit competitor
medic suppli industri gener view
switch cost intang asset cost advantag
like sourc underpin competit moat
focus enhanc product portfolio
acquisit isnt support moat
isol view dont see evid
moat sourc present product portfolio
center around low-cost single-us product reli
physician prefer group purchas group gpo
contract repeat sale deepli ingrain
switch cost either procur administr
end user addit firm margin profil
on-going manufactur consolid restructur
effort suggest us uniqu cost advantag current
exist -- although anticip margin improv
yet clear us abl dig
moat firm develop lead posit hand
market acquisit dont yet
confid meaning outperform
estim wacc decad believ
conting
manag abil sourc valu integr futur
acquisit constitut basi
moat histor profil support
stanc -- prior acquisit yet materi
enhanc firm return given substanti goodwil
alloc recur cost relat integr
restructur effort suggest deal valuat
expens side wed like see
evid valu creation adjust current view
howev think manag strategi target
product low absolut price point effect
hospit continu becom
sensit firm product portfolio somewhat uniqu
item carri sticker price less
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
come year manag optim compani
addit hesit award moat base
underinvest research develop
compar peer sinc transit pure play
medic busi compani spent
revenu averag research develop effort
versu peer bard
spent nearer high-single-digit percentag
revenu basi multipl
abl spend absolut dollar us impli
 compon strategi outsiz
impact rel competitor believ
put firm disadvantag environ
attract acquisit hard come
appear manag appetit acquisit
acceler cours close two deal
billion total valu think
deal includ interest asset dont believ
combin inher enhanc valu
combin compani competit posit expect
addit vascular solut neotract
improv firm growth margin profil howev
concern valuat paid limit
accret near term dont anticip impli
return sharehold deal exceed
estim firm cost capit three four
year doesnt jump us obvious value-add
proposit addit neotract repres one
riski opportun taken given
billion all-in price singl product firm
year commerci launch
view underli moat trend stabl
compani enjoy modest share gain year
undergon acquisit enhanc
firm posit tangenti market believ
product ad uniqu opportun
product portfolio dont view inclus
asset sustain improv weaken
underli competit posit
busi
addit valuat paid look expens
side rather obviou bargain calcul
manag commentari
accret combin near term us
limit return improv suggest underli
moat sourc unlik improv inclus
acquisit alon
believ potenti upsid exist base-cas
assumpt regard acquisit particularli
case neotract given larg unmet need within
benign prostat hyperplasia bph market want
remain cogniz bigger pictur believ teleflex
need continu sourc acquisit backfil
 pipelin increas uncertainti regard
develop platform abil busi
respond effect competit pressur view
addit either recent deal fail meet
expect believ materi risk capit
base given current make-up compani balanc
sheet case intang asset goodwil
make nearli total asset valu versu peer closer
averag pursu similar strategi
monitor progress deal
chang firm-wide care evid
posit neg inflect assess
final concern focus
product market limit barrier entri
product littl way intang
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
regul framework minim switch
cost outsid inertia part hospit procur
administr favor gpo relationship combin
underinvest intern worri
defens firm current market posit
given size scope primari competitor
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
gross margin profil meaning
improv higher margin vascular solut
neotract begin out-grow core franchis
clinic benefit area unmet need market
opportun substanti could repres home-
run acquisit sale continu grow current
product portfolio competit strategi
resembl bard could make
viabl take-out candid given bard pend tie
balanc sheet reach restrict
level manag pay debt
next year two return
acquisit could hamstr near-term
ohistor acquisit yet materi
compani profil given
substanti goodwil alloc -- verdict still
manag capit alloc prowess
goodwil intang asset much
larger portion balanc sheet compar
peer pursu similar strategi could indic
over-pay histor deal
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
view financi health reason
although recent acquisit activ rais leverag
histor level fiscal year debt/adjust
ebitda stood near time account
neotract acquisit modestli ahead time
rang compani oper last year
believ compani strong cash flow profil along
continu growth oper leverag allow
compani comfort de-lever time
adjust ebitda tax reform firm access
liquid markedli improv vast major
balanc sheet cash held oversea estim
firm approxim million tax-affect pension
oblig nearli million balanc sheet
leas financ modestli worsen compani overal
indebted profil combin billion
gross debt estim total obligation/adjust
ebitda ratio sit near time howev believ
compani adequ access liquid form
million annual free cash flow along million
current avail revolv line credit
assign high uncertainti rate due
indebt balanc sheet recent acquisit
increas risk otherwis stabl cash flow
profil near term would highlight potenti
valu destruct post-leadership transit
rel unconcern possibl given kelli
tenur addit expect integr
vascular solut neotract produc
wacc return capit within year high price
paid creat meaning risk capit base expect
growth fail materi addit highlight
risk stem firm limit invest
realiz return intern activ view
compani intern develop engin somewhat
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
lack would highlight materi underinvest
 vs peer spent roughli sale
 averag last five year versu bard
north becton dickinson near
better averag fill gap
acquisit anticip continu
find value-add candid critic firm
success go forward addit believ signific
portion compani product portfolio limit
protect custom switch cost enhanc
risk firm current market posit view
market environ provid acquisit
candid new manag team fail effect
sourc opportun think risk put
structur competit disadvantag time
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
share
fund
share
fund
award manag team standard mark
stewardship due success firm
leadership benson smith tenur ceo sinc
smith serv board member sinc
elev ceo role mark end histori
industri conglomer signal board
support firm strateg evolut pure-play
devic experi c-suit spent
nearli year career bard includ
late believ manag effect
alloc sharehold capit year
acquisit divestitur activ build
medic portfolio also like nich product
strategi compani pursu larg
insul busi price pressur seen broadli
across industri last year
howev smith retir ceo role end
preclud us award team except
rate although new ceo liam kelli part
compani execut team sinc held titl
sinc wed like get better sens
strateg vision capit alloc strategi firm
overal view manag compens reason
believ interest manag team
align minor sharehold insid
ownership encourag corpor director
offic own outstand share includ
underli option rsu smith own
annual
compens structur includ roughli equiti
base pay meaning vest period view
posit annual option grant vest ratabl
three-year period annual rsu vest entireti
three-year period perform metric base
compani addit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
primarili annual revenu ep target combin
weight tie oper cash flow
remain individu target think
consist mani compani cover wed
prefer heavier emphasi cash flow return capit
opinion better measur corpor
perform adjust incom statement item
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
report third quarter full-year
no-moat report solid third quarter
sure justifi stock move higher
hit think key metric investor --
organ revenu growth -- modestli higher low
qualiti manag outlook earn primari
near-term driver perform think investor
take long-term view valu firm compani
report quarter line expect plan
meaning chang forecast outsid updat
valuat time valu money fair
valu estim impli approxim time
adjust earn ebitda forecast
last quarter concern face uphil
battl meet manag organ growth
target due middl perform first half
year core organ growth come
quarter help addit
vascular solut vsi overal organ growth
measur near year-to-d basi result
guidanc appear attain although
highlight manag commentari suggest firm
like perform low end rang neotract
set annual firm organ growth bucket
quarter nuanc may becom difficult teas
time hope perform
larger platform acquisit continu disclos
vsi neotract continu perform well constitut
meaning growth engin firm vsi grew nearli
note abnorm weak compar period
case next quarter two-
year basi growth busi compar
second quarter although nice versu
face slowdown manag integr
compani neotract grew nearli pace meet
beat manag growth target full year
dissect surfac look like bump
full-year earn look like lower tax rate mask
million-dollar reduct non-gaap pre-tax incom
without tax benefit think guidanc suggest core
earn lower versu manag
prior expect look less line
quarter result would slightli shi
consensu lower-than-anticip tax
rate weaker core profit perform like
attribut combin effect less pronounc
currenc tailwind origin anticip along
manag reduct full-year adjust gross
oper margin guidanc roughli basi point
respect forecast alreadi low end
prior rang number like fall
relat
restructur expens origin thought
face uphil battl full-year
report rel weak second quarter
revenu oper profit fall shi
expect updat model like leav
per share fair valu estim no-moat rate
quarter character mani move part
suppli constraint variou product overal
exclud shipping-day varianc exit surgic
product compani put respect underli
growth although first
quarter includ net drag ship day
portfolio adjust first half grew
organ view main point investor
concern manag maintain growth guidanc
full year impli sizabl ramp
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
next six month acceler simpli
mechan lap close neotract
acquisit fourth quarter see ship day
benefit fulli includ vascular solut vsi
organ calcul said second half year
need show averag growth eye-pop
figur versu shown date estim
distributor order pattern suppli constraint affect
quarterli result basi point
provid small tailwind truli prove transient
regardless base busi need acceler
come month meet manag expect
hand two flagship acquisit
continu perform nice neotract handili beat
forecast vsi stabil weak quarter
investor like also spook manag implicit
reduct growth base busi
contribut neotract vsi expect
make basi point full-year forecast
basi point origin
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
